Translational Paediatric Oncology in the Era of Immunotherapy and Omics

A PhD course in Paediatric Oncology Research in March 2021 (online). The course will be given online, but requires active participation, full time Monday to Friday. Different formats (interactive plenary seminars, small-group discussions, oral student project presentations, e-poster discussions) will be implemented to foster interaction and active participation.

The course is open for PhD students and postdocs from all universities* and is held in English.

1.5 credits

Please apply before November 16 2020 in the link.

Information about application can be found here

*Order of priorities for admission: Students that previous applied for the course, PhD students at KI, PhD students elsewhere, Postdocs and Master students (are also welcome to apply)


The purpose of the course is

- To enable to obtain a comprehensive overview of the different domains within childhood cancer research and to understand the historical milestones forming the paradigms that have led to a cure of more than 8 out of 10 children with cancer 
- To give an insight into the current limitations and problems of childhood cancer treatment 
- To enable to get an understanding of how new methodologies in molecular biology increase our knowledge about tumourigenesis and tumour evolution. 
- To provide an opportunity to hypothesise and develop ideas about how to cure the remaining 2 out of 10 children with cancer – and how to cure with less side-effects. 

Comments from participants from the course evaluation 2018

"As a pediatric cancer researcher I can highly recommend this course to others in the same field, it was very interesting to hear about different types of cancers, the genetic mutations there, different types of treatment and so forth. The small group presentations were great, and it was a great opportunity to network with people and see the different projects and methods that exist.”

”The symposium during the last day of the course was very nice. The speakers presented their research and that was very constructive. Also, the diversity of the students regarding their background (for example molecular biologists, medical doctors etc.), as well as that if the people who either presented during the lectures or the symposium allowed us to see how different fields work together for the same cause. Last, but not least, the organization of the course was excellent.”

Course leaders

Frida Holm, Shanie Saghafian-Hedengren, Nikolas Herold, Malin Wickström and Désirée Gavhed

Childhood Cancer Research Unit, Department of Children’s and Women’s Health, Karolinska Institutet, Stockholm, Sweden